AlphaYouAR
Insider selling
Andrew Reardon sold $1.6M of Ligand Pharmaceuticals Inc (LGND) stock
Andrew Reardon, CLO & Secretary of Ligand Pharmaceuticals Inc (LGND), sold 5,000 shares of LGND stock worth $1.6M, per an SEC Form 4 filed Jul 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 30, 2026, 6 days before it was made public.
LGND has moved -5.6% since the trade date, from $316.09 to $298.50 (Sep 22, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jul 6, 2026
- Filing delay
- 6 days
- Price since
- -5.6%
- Role
- CLO & Secretary
- Source
- SEC Form 4
More LGND insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.